Nuclear physicists narrow the search for a rare nuclear decay that can explain the origin of matter in the universe.
Built with detector technologies used in nuclear physics experiments, the system monitors radiation treatments in hard-to-reach areas.
Production of actinium-227 ramps up for use in a drug to fight prostate cancer that has spread to bone.